Endo subsidiary announces nationwide recall of birth control

HUNTSVILLE, Ala. — Qualitest Pharmaceuticals, an Endo Pharmaceuticals subsidiary, issued a voluntary, nationwide recall of multiple lots of oral contraceptives at the retail level.

Qualitest said it recalled lots of the following birth control pills due to a packaging error, whereby select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date no longer visible. This error, the drug maker said, could leave women without adequate contraception and at risk for unintended pregnancy:

• 
  

  Cyclafem 7/7/7;

  
  


• 
  

  Cyclafem 1/35;

  
  


• 
  

  Emoquette;

  
  


• 
  

  Gildess FE 1.5/30;

  
  


• 
  

  Gildess FE 1/20;

  
  


• 
  

  Orsythia;

  
  


• 
  

  Previfem; and

  
  


• 
  

  Tri-Previfem.

  
  

The affected lot numbers can be found here.